(Q40461005)

20 September 2017

title

Remarkable response of juvenile diffuse sclerosing osteomyelitis of mandible to pamidronate. (English)

1 reference

20 September 2017

Yutaka Yamazaki

1

1 reference

20 September 2017

Chiharu Satoh

2

1 reference

20 September 2017

Makoto Ishikawa

3

1 reference

20 September 2017

Ken-ichi Notani

4

1 reference

20 September 2017

Katsuhiro Nomura

5

1 reference

20 September 2017

Yoshimasa Kitagawa

6

1 reference

20 September 2017

publication date

2 January 2007

1 reference

Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics

20 September 2017

published in

1 reference

20 September 2017

volume

104

1 reference

20 September 2017

issue

1

1 reference

20 September 2017

page(s)

67-71

1 reference

Diffuse sclerosing osteomyelitis of the mandible

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.09.021

Diffuse sclerosing osteomyelitis of the mandible: clinical radiographic and histologic findings in twenty-seven patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.09.021

Radiographic evaluation of possible etiology of diffuse sclerosing osteomyelitis of the mandible

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.09.021

Treatment and prognosis of diffuse sclerosing osteomyelitis (DSO) of the mandible

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.09.021

Overview of bisphosphonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.09.021

American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.09.021

Pamidronate in the treatment of diffuse sclerosing osteomyelitis of the mandible

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.09.021

Disodium clodronate in the treatment of diffuse sclerosing osteomyelitis (DSO) of the mandible

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.09.021

Successful management of severe facial pain in patients with diffuse sclerosing osteomyelitis (DSO) of the mandible using disodium clodronate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.09.021

Response of diffuse sclerosing osteomyelitis of the mandible to alendronate: follow-up study by 99mTc scintigraphy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.09.021

Physeal involvement in chronic recurrent multifocal osteomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.09.021

The significance of carboxy-terminal telopeptide of type I collagen (ICTP) and osteocalcin (OC) in assessment of bone disease in patients with multiple myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.09.021

Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.09.021

Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.09.021

Possible identity of diffuse sclerosing osteomyelitis and chronic recurrent multifocal osteomyelitis. One entity or two.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.09.021

10.1016/J.TRIPLEO.2006.09.021

7 January 2021

Identifiers

DOI

1 reference

20 September 2017

1 reference